Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1179 |  KOD Kodiak Sciences Inc - Common Stock | 94.26 USD | +3.49% | -3.96% | +173.46% | +556.41% | 5.92 B USD | ||
| 1182 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 295.00 USD | +0.59% | -4.08% | +2.42% | +57.65% | 5.88 B USD | ||
| 1248 |  ERAS Erasca, Inc. - Common Stock | 15.46 USD | +9.49% | +4.39% | -3.74% | +536.21% | 5.41 B USD | ||
| 1266 |  MIRM Mirum Pharmaceuticals, Inc. - common stock | 81.35 USD | +0.88% | -3.93% | -17.01% | +16.00% | 5.28 B USD | ||
| 1272 |  PTCT PTC Therapeutics, Inc. - Common Stock | 62.56 USD | -1.06% | -3.47% | -8.11% | -2.95% | 5.22 B USD | ||
| 1273 |  COGT Cogent Biosciences, Inc. - Common Stock | 30.08 USD | -0.20% | -6.35% | -14.28% | +91.96% | 5.22 B USD | ||
| 1284 |  SRRK Scholar Rock Holding Corporation - Common Stock | 42.20 USD | 0.00% | -9.71% | -26.38% | +40.57% | 5.14 B USD | ||
| 1317 |  TVTX Travere Therapeutics, Inc. - Common Stock | 52.04 USD | -2.62% | -9.04% | -20.91% | +80.88% | 4.91 B USD | ||
| 1318 |  CRSP CRISPR Therapeutics AG - Common Shares | 50.44 USD | -3.65% | -10.65% | -7.45% | -35.17% | 4.88 B USD | ||
| 1360 |  DNTH Dianthus Therapeutics, Inc. - Common Stock | 82.43 USD | -2.89% | -7.43% | -23.70% | +137.21% | 4.61 B USD | ||
| 1364 |  DFTX Definium Therapeutics, Inc. - Common Shares | 34.18 USD | -2.59% | -9.34% | -9.62% | +126.21% | 4.59 B USD | ||
| 1417 |  EWTX Edgewise Therapeutics, Inc. - Common Stock | 39.23 USD | -0.86% | -4.34% | -8.83% | +157.58% | 4.26 B USD | ||
| 1436 |  ADPT Adaptive Biotechnologies Corporation - Common Stock | 26.09 USD | -0.72% | -5.44% | +8.48% | +51.16% | 4.16 B USD | ||
| 1498 |  RLAY Relay Therapeutics, Inc. - Common Stock | 17.41 USD | -3.01% | -6.95% | -7.20% | +183.09% | 3.82 B USD | ||
| 1500 |  TNGX Tango Therapeutics, Inc. - Common Stock | 22.57 USD | +3.39% | -10.04% | -0.27% | +227.10% | 3.81 B USD | ||
| 1510 |  TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.01 USD | -0.99% | +3.48% | -8.93% | +74.48% | 3.73 B USD | ||
| 1517 |  ABCL AbCellera Biologics Inc. - Common Shares | 12.02 USD | -6.31% | -14.75% | +5.72% | +95.13% | 3.69 B USD | ||
| 1549 |  VCYT Veracyte, Inc. - Common Stock | 43.60 USD | +1.02% | -2.98% | +1.89% | +18.16% | 3.51 B USD | ||
| 1550 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 36.16 USD | -0.69% | -7.52% | -38.75% | -11.35% | 3.50 B USD | ||
| 1553 |  IDYA IDEAYA Biosciences, Inc. - Common Stock | 36.06 USD | -0.55% | -6.39% | -7.16% | +10.68% | 3.48 B USD |
Notícias Biotechnology Stocks
Raymond James inicia cobertura da Kymera Therapeutics com recomendação acima da média
Raymond James inicia cobertura da Nektar com classificação de desempenho de mercado
Ação da Palisade Bio inicia cobertura com Outperform na Raymond James
Raymond James mantém recomendação para ações da Liquidia em meio a processos judiciais
Ginkgo Bioworks vai apoiar o programa NSF X-Labs com acesso a laboratório
AbCellera apresentará dados de fase 1/2 sobre candidato a medicamento para menopausa
Quantum-Si detecta 19 aminoácidos no programa de desenvolvimento Proteus
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |